中国临床药学杂志

参考文献

[1]金有豫.药理学[M].北京:人民卫生出版社,2001.2021.

[2]韩兴梅,周宏灏.CYP1A2的多态性与癌症易感性[J].中国药理学报,2000,21(8):673.

[3]马小超,屠曾宏.细胞色素P4501A2的研究进展[A].见:苏定冯,缪朝玉,王永铭,主编.药理学进展[M].北京:人民卫生出版社,2003.2531.

[4]NakajimaM ,YokoiT ,MizutaniM .Geneticpolymorphisminthe5’ flankingregionofhumanCYP1A2gene:effectontheCYP1A2in ducibilityinhumans[J].JBiochem,1999,125(4):803.

[5]SachseC ,BrockmollerJ,BauerS .FunctionalsignificanceofaC→Apolymorphisminintron1ofthecytochromeP450CYP1A2genetestedwithcaffeine[J].BrJClinPharmacol1999,47(4):445.

[6]韩兴梅,陈小平,吴启南,等.中国人群中CYP1A2基因G 2964A和C734A多态性分布[J].中国药理学报,2000,21(11):1031.

[7]许振华,周宏灏.细胞色素氧化酶P4501A2与药物代谢[J].中国临床药理学杂志,1996,12(2):115.

[8]JanGH ,BartVDB ,PabloS ,etal.Interspeciesdifferencesincancersusceptibilityandtoxicity[J].DrugMetabRev,1999,31(4):917.

[9]DanielWN ,AmyLR .Ethnicandgeneticdifferencesinmetabolismgenesandriskoftoxicityandcancer[J].SciTotalEnviro,2001,274(13):93.

[10]程泽能,舒焱,刘昭前,等.体外研究人细胞色素P450在雌二醇代谢中的作用[J].中国药理学报,2001,22(2):148.

[11]TsudaH ,SekineK ,FujitaK ,etal.Cancerpreventionbybovinelacto ferrinandunderlyingmechanisms areviewofexperimentalandclinicalstudies[J].BiochemCellBiol,2002,80(1):131.

[12]潘家祜.药物代谢动力学研究方法[A].见:徐叔云,主编.药理实验方法学[M].第3版.北京:人民卫生出版社,2002.714716.